Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients.

Frontiers in immunology·2023
Same author

Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.

PloS one·2022
Same author

Prenatal disruption of blood-brain barrier formation via cyclooxygenase activation leads to lifelong brain inflammation.

Proceedings of the National Academy of Sciences of the United States of America·2022
Same author

Immune Regulatory Cell Bias Following Alemtuzumab Treatment in Relapsing-Remitting Multiple Sclerosis.

Frontiers in immunology·2021
Same author

Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis.

Journal of neuroinflammation·2020
Same author

Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2019
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 6, 2026

Classification of Neural Stem Cell Activation State In Vitro Using Autofluorescence
06:56

Classification of Neural Stem Cell Activation State In Vitro Using Autofluorescence

Published on: April 12, 2024

Measuring apoptosis in neural stem cells.

Brett T Lund1, Eve E Kelland

  • 1Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|March 29, 2008
PubMed
Summary
This summary is machine-generated.

Human embryonic stem cells (hESCs) show therapeutic potential for central nervous system (CNS) diseases. Protocols were developed to assess apoptosis in hESCs, crucial for successful CNS stem cell therapy.

More Related Videos

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
12:44

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells

Published on: October 11, 2012

Related Experiment Videos

Last Updated: Jul 6, 2026

Classification of Neural Stem Cell Activation State In Vitro Using Autofluorescence
06:56

Classification of Neural Stem Cell Activation State In Vitro Using Autofluorescence

Published on: April 12, 2024

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
12:44

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells

Published on: October 11, 2012

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Cell Death Research

Background:

  • Apoptotic events are common in central nervous system (CNS) damage and disease.
  • Human embryonic stem cells (hESCs) are potential therapeutics for CNS disorders.
  • Stem cell therapy success hinges on cell survival and resistance to apoptosis post-transplantation.

Purpose of the Study:

  • To describe protocols for assessing apoptosis in human embryonic stem cells (hESCs) and their progeny.
  • To address the limited methods for evaluating apoptosis in adherent stem cell cultures.

Main Methods:

  • Development and application of specific protocols to detect apoptosis.
  • Assessment of apoptosis in adherent cultures of hESCs and derived cells.

Main Results:

  • Established protocols effectively assess apoptosis in hESCs and their progeny.
  • Demonstrated methods for evaluating the survival capacity of stem cells in CNS-relevant contexts.

Conclusions:

  • The described protocols provide a means to evaluate hESC apoptosis, vital for CNS regenerative medicine.
  • Accurate apoptosis assessment is critical for advancing stem cell-based therapies for neurological conditions.